image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 5.88
-4.39 %
$ 420 M
Market Cap
8.78
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one SIGA stock under the worst case scenario is HIDDEN Compared to the current market price of 5.88 USD, SIGA Technologies, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one SIGA stock under the base case scenario is HIDDEN Compared to the current market price of 5.88 USD, SIGA Technologies, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one SIGA stock under the best case scenario is HIDDEN Compared to the current market price of 5.88 USD, SIGA Technologies, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SIGA

image
$6.2$6.2$6.0$6.0$5.8$5.8$5.6$5.6$5.4$5.4$5.2$5.2$5.0$5.0$4.8$4.8$4.6$4.615 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
139 M REVENUE
-0.86%
70 M OPERATING INCOME
-16.31%
59.2 M NET INCOME
-13.01%
48.8 M OPERATING CASH FLOW
-48.56%
-42.4 K INVESTING CASH FLOW
-95.75%
-43.5 M FINANCING CASH FLOW
-0.10%
7.04 M REVENUE
-91.36%
-2.26 M OPERATING INCOME
-3.95%
-408 K NET INCOME
-0.89%
7.06 M OPERATING CASH FLOW
-87.46%
-24.9 K INVESTING CASH FLOW
-39.55%
-166 K FINANCING CASH FLOW
-2.74%
Balance Sheet SIGA Technologies, Inc.
image
Current Assets 231 M
Cash & Short-Term Investments 155 M
Receivables 21.2 M
Other Current Assets 54.5 M
Non-Current Assets 13.3 M
Long-Term Investments 0
PP&E 1.3 M
Other Non-Current Assets 12 M
63.60 %8.66 %22.30 %4.91 %Total Assets$244.3m
Current Liabilities 25.3 M
Accounts Payable 1.34 M
Short-Term Debt 547 K
Other Current Liabilities 23.4 M
Non-Current Liabilities 3.2 M
Long-Term Debt 0
Other Non-Current Liabilities 3.2 M
4.70 %82.17 %11.22 %Total Liabilities$28.5m
EFFICIENCY
Earnings Waterfall SIGA Technologies, Inc.
image
Revenue 139 M
Cost Of Revenue 43.6 M
Gross Profit 95.1 M
Operating Expenses 25.1 M
Operating Income 70 M
Other Expenses 10.8 M
Net Income 59.2 M
140m140m120m120m100m100m80m80m60m60m40m40m20m20m00139m(44m)95m(25m)70m(11m)59mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
68.57% GROSS MARGIN
68.57%
50.45% OPERATING MARGIN
50.45%
42.69% NET MARGIN
42.69%
27.44% ROE
27.44%
24.23% ROA
24.23%
24.81% ROIC
24.81%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis SIGA Technologies, Inc.
image
100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 59.2 M
Depreciation & Amortization 538 K
Capital Expenditures -42.4 K
Stock-Based Compensation 3.64 M
Change in Working Capital -4.69 M
Others -9.38 M
Free Cash Flow 48.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets SIGA Technologies, Inc.
image
SIGA has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.6 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.201.201.001.000.800.800.600.600.400.400.200.200.000.000.60.451.050.450.450.60.600.0020222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 14
6. Ownership
Insider Ownership SIGA Technologies, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
SIGA Technologies, Inc. (SIGA) Q1 2025 Earnings Call Transcript SIGA Technologies, Inc. (NASDAQ:SIGA ) Q1 2025 Results Conference Call May 8, 2025 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Dan Luckshire - Executive Vice President & Chief Financial Officer Conference Call Participants Jyoti Prakash - Edison Group Operator Good afternoon. Welcome to SIGA Technologies business update call. seekingalpha.com - 1 month ago
SIGA Reports Financial Results for Three Months Ended March 31, 2025 Received $26 Million IV TPOXX Procurement Order from the U.S. Government in March $94 million in TPOXX Orders (to be Delivered to U.S. Strategic National Stockpile) outstanding as of March 31, 2025 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2025. “SIGA has carried its momentum from 2024 into 2025, achieving steady progress on its key initiatives,” stated Diem Nguyen, Chief Executive Officer. globenewswire.com - 1 month ago
Siga Technologies Inc. (SIGA) Stock Declines While Market Improves: Some Information for Investors In the most recent trading session, Siga Technologies Inc. (SIGA) closed at $5.43, indicating a -1.63% shift from the previous trading day. zacks.com - 1 month ago
SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 8, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. globenewswire.com - 1 month ago
Here's Why Siga Technologies Inc. (SIGA) Gained But Lagged the Market Today Siga Technologies Inc. (SIGA) reachead $6.51 at the closing of the latest trading day, reflecting a +0.39% change compared to its last close. zacks.com - 1 month ago
Siga Technologies Inc. (SIGA) Outperforms Broader Market: What You Need to Know The latest trading day saw Siga Technologies Inc. (SIGA) settling at $6.25, representing a +1.96% change from its previous close. zacks.com - 1 month ago
Siga Technologies Inc. (SIGA) Falls More Steeply Than Broader Market: What Investors Need to Know In the latest trading session, Siga Technologies Inc. (SIGA) closed at $6.04, marking a -1.79% move from the previous day. zacks.com - 2 months ago
SIGA Declares Special Cash Dividend of $0.60 Per Share NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company's common stock. This represents the fourth straight year of a special cash dividend. The amount of the dividend declared is consistent with the level of the dividend declared in March 2024. The dividend is payable on May 15, 2025, to shareholders of record at the close of business on April 29, 2025. globenewswire.com - 2 months ago
Siga Technologies Inc. (SIGA) Declines More Than Market: Some Information for Investors In the most recent trading session, Siga Technologies Inc. (SIGA) closed at $5.32, indicating a -1.3% shift from the previous trading day. zacks.com - 2 months ago
SIGA Technologies: Asymmetric Upside, If 2025 Goes Right SIGA Technologies' strong cash position and high FCF margins provide a valuation floor, but growth is limited without new catalysts, supporting a "speculative Buy" rating. Key 2025 catalysts include potential PEP approval and a new BARDA contract, which could significantly boost SIGA's valuation. SIGA's reliance on unpredictable orthopoxvirus outbreaks and government funding poses risks, making it suitable for a barbell portfolio with speculative investment. seekingalpha.com - 2 months ago
Siga Technologies Inc. (SIGA) Stock Slides as Market Rises: Facts to Know Before You Trade In the latest trading session, Siga Technologies Inc. (SIGA) closed at $5.74, marking a -0.35% move from the previous day. zacks.com - 3 months ago
SIGA Appoints Retired General John M. Keane to its Board of Directors NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, announced today the appointment of Retired United States Army General John “Jack” Keane to its Board of Directors, effective immediately. General Keane, a retired four-star general, completed 37 years of public service in December 2003, culminating with his appointment as acting Chief of Staff and Vice Chief of Staff of the U.S. Army from 1999 to 2003. globenewswire.com - 3 months ago
8. Profile Summary

SIGA Technologies, Inc. SIGA

image
COUNTRY US
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 420 M
Dividend Yield 0.00%
Description SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Contact 31 East 62nd Street, New York City, NY, 10065 https://www.siga.com
IPO Date Sept. 10, 1997
Employees 46
Officers Ms. Tove C. Bolken Senior Vice President of Operations & Chief Supply Chain Officer Mr. Daniel J. Luckshire CPA, M.B.A. Executive Vice President, Chief Financial Officer & Secretary Mr. Herb Vloedman Senior Vice President & Chief Information Officer Dr. Dennis E. Hruby Ph.D. Executive Vice President & Chief Scientific Officer Dr. Diem Nguyen M.B.A., Ph.D. Chief Executive Officer & Director Mr. Lawrence R. Miller Esq., J.D. General Counsel & Corporate Secretary